A Study to Assess the Experimental Malaria Vaccines RH5.2-VLP and R21
Condition:   Malaria, Plasmodium Falciparum Intervention:   Biological: Matrix-M with RH5.2 VLP and/or R21 Sponsors:   University of Oxford;   European and Developing Countries Clinical Trials Partnership (EDCTP);   Medical Research Council Unit The Gambia at the LSHTM (MRCG) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2022 Category: Research Source Type: clinical trials

Safety and Immunogenicity of Pvs25-IMX313/Matrix-M1 Vaccine
Condition:   Malaria, Vivax Intervention:   Biological: Pvs25-IMX313/Matrix-M1 Sponsor:   University of Oxford Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2022 Category: Research Source Type: clinical trials